BRCA2 and ovarian cancer: Ovarian cancer has a significant genetic component, and population-based screenings show that 14.5% of all patients have at least one pathogenic variant with BRCA1, BRCA2, CHEK2, BRIP1, and MSH2 being the most prevalent ones [2].